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Objective: assess the adherence levels to antiretroviral therapy in people coinfected with HIV/
tuberculosis and correlate these levels with the sociodemographic and clinical variables of the 
study population. Method: cross-sectional study involving 74 male and female adults coinfected 
with HIV/tuberculosis. For the data collection, a sociodemographic and clinical assessment form 
and the Antiretroviral Treatment Adherence Assessment Questionnaire were used. For the data 
analysis, the software STATA version 11 was used, through descriptive statistics, Fisher’s chi-
square exact test and the probability test. Results: men were predominant (79.7%), between 
30 and 39 years of age (35.1%), low income (75.7%) and pulmonary tuberculosis (71.6%). 
Adherence to antiretroviral therapy was inappropriate in 78.1% of the men; 61.0% of single 
people; 47.0% unemployed and 76.5% among people gaining less than one minimum wage. 
A significant difference was observed between compliance and length of use of antiretrovirals 
(p=0.018), sexual orientation (p=0.024) and number of children (p=0.029). Conclusion: the 
coinfected patients presented inappropriate adherence to the antiretrovirals, a fact that negatively 
affects the health conditions of the people living with HIV/tuberculosis coinfection. A statistically 
significant correlation was found between the levels of adherence and some sociodemographic 
and clinical characteristics.
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Introduction
Infection by the Human Immunodeficiency Virus 
(HIV) has been considered one of the main risk factors 
for the development of active Tuberculosis (TB), based on 
a latent infection in people infected with Mycobacterium 
tuberculosis(1).
HIV infection represents a significant challenge for 
global TB control. TB is the second main cause of death 
by infectious diseases all over the world and the main 
cause among people living with HIV. Approximately 
13.0% of TB cases happen in people living with HIV(2).
Compliance with TB and HIV/AIDS treatment is 
fundamental to control these infections as, despite being 
considered chronic infection, tuberculosis treatment 
takes between six and nine months, depending on the 
type of TB, while HIV/AIDS treatment lasts a lifetime(3).
HIV/TB coinfection results in higher mortality rates 
than HIV infection only(4). Resistance to tuberculostatic 
drugs, as well as the high risk of transmitting the 
TB bacillus, emerged due to the abandonment and 
inappropriate use of drugs against TB. People living 
with HIV are at greater risk of reactivating the latent 
tuberculosis infection due to the deficient immune 
response. In coinfected people, mortality is commonly 
related with late diagnosis, as some people with HIV 
postpone visiting a health service out of fear of receiving 
an AIDS diagnosis(5).
Concerning the disease evolution, the reduced 
survival of HIV/AIDS patients has been observed after the 
development of active TB. In addition, the HIV infection 
changes the TB infection, its clinical manifestation, the 
length of the treatment and tolerance of tuberculostatic 
drugs. As a result of correct treatment, however, 
approximately 90.0% of coinfected patients with active 
TB can be cured and discharged(6).
Antiretroviral Therapy (ARVT) significantly reduces 
the risk of morbidity and mortality due to TB. A study 
appoints that the appropriate use of ARVT reduces the 
risk of developing TB by 65.0%, independently of the T 
CD4+ lymphocyte count(7).
People being concomitantly treated for both 
diseases can be at risk of reduced adherence to one 
or both treatments. The low compliance with TB and 
HIV treatment can lead to the increased risk of drug 
resistance, relapses, death and, in addition, extend the 
infectiousness(8).
The characteristics frequently appointed in 
research concerning adherence to medication related 
to different health conditions include patients’ social, 
environmental, cultural and psychological aspects, as 
well as the characteristics intrinsic to the treatment(1).
In view of the above, the goals were to assess the 
compliance levels with antiretroviral therapy in patients 
coinfected with HIV/tuberculosis and to correlate these 
levels with the sociodemographic and clinical variables 
of the study population.
Method
A descriptive and cross-sectional study was 
undertaken at a public teaching and referral hospital for 
the diagnosis and treatment of infectious diseases in the 
State of Ceará. The data were collected in a consecutive 
period of six months, from September 2012 till January 
2013.
The population consisted of 74 people coinfected 
with HIV/TB and monitored at the service’s outpatient 
clinic, whose inclusion criteria were: age 18 years or 
older, male or female, with a medical diagnosis of HIV and 
tuberculosis (HIV/TB coinfection), formally registered in 
the patient history. This number represented 90.2% of 
all coinfected patients attended at the service during the 
research period.
The participants were recruited for the study while 
attending their routine outpatient consultation. The 
interviews were held at a private room, permitting the 
secrecy and confidentiality of the information obtained.
To collect the data, a sociodemographic and clinical 
assessment tool was used. The variables obtained from 
primary sources were: age, sex, self-referred color, 
education, occupation, income, marital situation, sexual 
orientation, number of children and number of people 
living in the same home. The clinical data were: current 
serum status of partner, length of diagnosis of HIV 
infection, length of use of T CD4+ lymphocyte counts, 
viral load and form of exposure to tuberculosis.
To assess the compliance with antiretroviral 
treatment, the Brazilian version of the Antiretroviral 
Treatment Adherence Assessment Questionnaire (CEAT-
HIV) was used, a tool applicable to people infected with 
HIV, containing 20 questions, in which the total score is 
obtained by adding up all item scores (minimum possible 
score 17, maximum possible score 89). The higher the 
score, the higher the degree of treatment compliance. 
The degree of compliance follows these categories: 
inappropriate or low/insufficient (gross score ≤74), 
good/appropriate (gross score between 75 and 79) and 
strict (gross score ≥80)(9). In this study, for the purpose 
of the data analysis, considering that Fisher’s exact 
chi-square test was used, adherence was classified 
as good/appropriate and strict (gross score ≥75) and 
inappropriate or low/insufficient (gross score ≤74). 
Inappropriate adherence is characterized by complete 
treatment abandonment or incorrect follow-up.
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For the statistical analyses, the software STATA 
version 11.0 was used. The sociodemographic and clinical 
characteristics were processed through descriptive 
statistics, uni and bivariate frequency distributions and 
descriptive measures (average and standard deviation). 
The p-values were obtained using Fisher’s exact chi-
square test and the probability test. Significance was 
set at 5.0% (p≤0.05).
The study received approval from the Research 
Ethics Committee under Protocol 93.437, complying 
with the recommendations of National Health Council 
Resolution 466/2012.
Results
Among the 74 persons investigated, 79.7% were 
male. The predominant age range was between 30 
and 39 years (35.1%), with a mean age of 37.7 years 
(standard deviation-sd=10.88), minimum age 20 years 
and maximum age 71 years.
In the distribution of the self-referred color, mulatto 
individuals were predominant (58.1%). As to the marital 
status, 31.1% were married or lived with a fixed partner. 
Concerning the sexual orientation, 61.7% indicated 
they were heterosexual. Regarding education, 42.4% 
reported they had finished secondary education, with an 
average of approximately 9.3 years of study, minimum 0 
and maximum 20 years of study. What the professional 
situation is concerned, it was observed that 40.5% were 
unemployed and 75.7% gained an income of less than 
one minimum wage (Table 1).
With regard to medication adherence, for this 
study, only consent with the antiretroviral therapy 
was considered, as the literature does not present any 
validated tool to measure compliance with ARVT and 
tuberculostatic drugs at the same time among patients 
confected with HIV/TB.
In Table 1, the correlations between the 
sociodemographic characteristics and the levels of 
compliance with the antiretroviral drugs are observed 
among the patients coinfected with HIV/TB. In the total 
group, 10 (13.5%) were classified under appropriate 
adherence, and 64 (86.5%) presented inappropriate 
levels.
When the variables sex, age, color, marital situation, 
education, occupation, income and number of people 
living at the same home were assessed, correlated with 
the adherence levels, no statistically significant differences 
were observed. On the opposite, statistically significant 
proportional differences were obtained between sexual 
orientation and adherence (p=0.024) and number of 
children and adherence (p=0.029) (Table 1).
Variables
Adherence to ARVT* Total
PAppropriate
N (%)
Inappropriate 
N (%) N (%)
Sex 0.676
Male 9 (90.0) 50 (78.1) 59 (79.7)
Female 1 (10.0) 14 (21.9) 15 (20.3)
Age (years) 0.22
Up to 29 4 (40.0) 14 (21.9) 18 (24.3)
30–39 3 (30.0) 23 (36.0) 26 (35.1)
40–49 3 (30.0) 20 (31.2) 23 (31.1)
50–59 0 (0.0) 3 (4.7) 3 (4.1)
≥60
0 (0.0) 4 (6.2) 4 (5.4)
Self-referred color 1.000
White 4 (40.0) 26 (40.6) 30 (40.5)
Black 0 (0.0) 1 (2.5) 1 (1.4)
Mulatto 6 (60.0) 37 (57.9) 43 (58.1)
Marital situation 0.768
Married/Fixed partner 3 (30.0) 17 (26.5) 20 (27.0)
Single 7 (70.0) 39 (61.0) 46 (62.2)
Others 0 (0.0) 8 (12.5) 8 (10.8)
Sexual orientation 0.024
Heterosexual 5 (50.0) 43 (67.2) 48 (64.9)
Homosexual 5 (50.0) 9 (14.0) 14 (18.9)
Bisexual 0 (0.0) 12 (18.8) 12 (16.2)
(continue...)
Table 1 – Distribution of sociodemographic characteristics of 74 patients coinfected with HIV/tuberculosis and 
compliance levels with antiretrovirals. Fortaleza, CE, Brazil, 2012
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Table 1 - (continuation)
Variables
Adherence to ARVT* Total
PAppropriate
N (%)
Inappropriate 
N (%) N (%)
Education 0.21
Illiterate 0 (0.0) 6 (9.3) 6 (8.1)
Primary education 2 (20.0) 30 (46.9) 32 (43.2)
Secondary education 7 (70.0) 28 (43.8) 35 (47.3)
Higher education 1 (10.0) 0 (0.0) 1 (1.4)
Occupation 0.828
Employed 3 (30.0) 13 (20.3) 16 (21.6)
Unemployed 4 (40.0) 26 (40.7) 30 (40.5)
Others 3 (30.0) 25 (39.0) 28 (37.9)
Income (minimum wage)† 0.672
<1 7 (70.0) 49 (76.5) 56 (75.7)
1-2 2 (20.0) 12 (18.7) 14 (18.9)
>2 1 (10.0) 3 (4.69) 4 (5.4)
Number of children 0.029
0 8 (80.0) 22 (34.4) 30 (40.6)
1-2 1 (10.0) 21 (32.8) 22 (29.7)
≥3
1 (10.0) 21 (32.8) 22 (29.7)
Number of people living per home 0.421
1 0 (0.0) 11 (17.1) 11 (14.9)
2-3 5 (50.0) 21 (32.8) 26 (35.2)
≥4
5 (50.0) 32 (50.0) 37 (50.0)
*Antiretroviral therapy; †Minimum wage in 2012 in Brazil: R$622.00.
When assessing the HIV/TB coinfected patients’ 
clinical characteristics and the correlation with the level of 
adherence, it was observed that, concerning knowledge 
of the sexual partner’s serum status of the 23 people 
whose partners took the anti-HIV test, adherence was 
inappropriate in 86.9% (n=20), independently of the 
test result. The three people with appropriate adherence 
had a seroconcordant current sexual partner (Table 2).
Variables
Compliance with ARVT * Total
pAppropriate
N (%) Inappropriate N (%) N (%)
Serum status of partner (n=23)
1.000
Positive (n=16) 3 (100.0) 13 (65.0) 16 (69.7)
Negative (n=3) 0 (0.0) 3 (15.0) 3 (13.0)
Does not know/not tested (n=4) 0 (0.0) 4 (20.0) 4 (17.4)
Length of HIV diagnosis (years)
0.680
<1 6 (60.0) 28 (43.8) 34 (46.9)
1-5 3 (30.0) 22 (34.3) 25 (33.8)
>5 1 (10.0) 14 (21.9) 15 (20.3)
Statistical significance was obtained for the length 
of use of ARVT and compliance levels (p=0.018), but 
the other variables (serum status of partner, length of 
diagnosis, CD4+ count, viral load and hospitalizations) 
showed no proportional similarity, as the p-values were 
higher than 0.05 (p≥0.05).
Table 2 – Distribution of clinical characteristics of 74 patients coinfected with HIV/tuberculosis and compliance levels 
with antiretrovirals. Fortaleza, CE, Brazil, 2012
Table 2 - (continuation)
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When analyzing the forms of exposure to 
tuberculosis, the predominance of the pulmonary form 
was demonstrated and, concerning the correlation with 
adherence to ARVT, no statistically significant difference 
was observed (p=0.374) (Table 3).
Table 2 - (continuation)
Variables
Compliance with ARVT * Total
pAppropriate
N (%) Inappropriate N (%) N (%)
T CD4+ lymphocytes (cells/mm³)
0.528
<200 7 (70.0) 31 (48.5) 38 (51.4)
200-499 3 (30.0) 29 (45.3) 32 (43.2)
≥500 0 (0.0) 4 (6.2) 4 (5.4)
Viral load (copies/ml)
0.190
<50 5 (50.0) 14 (22.0) 19 (25.7)
50-10.000 1 (10.0) 9 (14.0) 10 (13.5)
>10.000 4 (40.0) 41 (64.0) 45 (60.8)
Length of use of ARVT (months)
0.018
<6 2 (20.0) 34 (53.1) 36 (48.6)
6-12 5 (50.0) 8 (12.5) 13 (17.6)
>12 3 (30.0) 22 (34.4) 25 (33.8)
Hospitalizations due to complications of 
HIV
0.7490 4 (40.0) 18 (28.1) 22 (29.7)
1-2 4 (40.0) 33 (51.5) 37 (50.0)
>3 2 (20.0) 13 (20.4) 15 (20.3)
*Antiretroviral therapy.
Type of 
tuberculosis
Compliance with ARVT * Total
PAppropriate
N (%)
Inappropriate
N (%) N (%)
Pulmonary 6 (60.0) 47 (73.4) 53 (71.6) 0.374
Extrapulmonary 4 (40.0) 13 (20.3) 17 (22.9)
Pulmonary + 
extrapulmonary 
(mixed)
0 (0.0) 4 (6.3) 4 (5.4)
Table 3 – Distribution of tuberculosis presentation 
forms and levels of compliance with antiretrovirals of 
74 patients coinfected with HIV/tuberculosis. Fortaleza, 
CE, Brazil, 2012
*Antiretroviral therapy
Discussion
Similar to the present findings, the HIV/TB 
coinfection was more frequent in individuals between 
30 and 39 years of age, representing the economically 
most active part of the population(10-11). In Brazil, the 
AIDS epidemic has grown among younger individuals 
and women. As observed in other studies(11-12), however, 
the population with HIV/TB coinfection predominantly 
included men of economically productive age.
Among the study variables, education is strongly 
associated with precarious socioeconomic conditions. 
Using it as a substitute measure of poverty, this suggests 
that people with this coinfection are in a situation of 
impoverishment, with a reduced ability to cope with the 
consequences of diseases due to the deficient access to 
preventive, diagnostic and curative services(13).
A significant association was reported between 
HIV/TB coinfection and living in an urban area and 
extrapulmonary TB. After the establishment of AIDS, it 
is known that the extrapulmonary forms of TB become 
more common(10). Concerning the form of TB, this 
information differs from the present study findings, in 
which pulmonary tuberculosis was the predominant 
clinical form in people living with HIV.
As regards the occupational situation, there 
are high unemployment rates among coinfected 
patients. This finding was also observed in this study, 
demonstrating that the economic and social difficulties 
can influence their professional possibilities, maintaining 
their conditions of poverty(14).
In another study, the professional activity was 
mentioned as one of the most relevant factors to 
cope with the condition of the HIV infection. The work 
environment was appointed as a place of contact and 
experience exchange among people, favoring mental 
coping with the infection. In the disease situation, the 
availability of social support raises the self-esteem and 
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the desire to live, contributing to the success of their 
treatment(15).
The participants in this study presented low T 
CD4+ cell counts and a high viral load, supporting the 
literature and indicating that TB is an opportunistic 
infection, strongly associated with the decrease of the 
immunological system. It is observed that, overall, 
people coinfected with HIV/TB present greater immune 
system problems when compared to people who simply 
suffer from HIV infection in the asymptomatic phase(12).
The most frequent difficulties people living with 
HIV/TB coinfection face are related to socioeconomic 
aspects, social factors, lifestyle and difficulties with the 
therapeutic regimens and with the intervals between 
the drug doses, characterized as motives that interfere 
significantly in continuing and effective adherence(16).
The treatment of coinfected people tends to be 
difficult. TB patients need long-term treatment with 
different drugs. For HIV/TB patients, compliance with 
the therapeutic scheme is difficult as they have to 
use concomitant drugs to treat both infections(10). This 
situation may have contributed to the predominantly 
inappropriate compliance with ARVT in this study.
A study indicates that the variables significantly 
associated with non-compliance with the double therapy 
were: male sex, low income, presence of three or more 
chronic conditions, having a knowingly HIV-positive 
partner and sexual relationships in the previous three 
months(1).
In a study aimed at identifying the determinants of 
medication compliance in patients coinfected with HIV/
TB, it was demonstrated that a large number of people 
living at the same home, lack of financial resources 
to promote self-care and deficient knowledge on the 
diseases were factors that interfered in appropriate 
adherence to the medication. The sociodemographic 
variables were not considered as predictive factors that 
influenced medication adherence(3), differently from the 
scientific hypothesis formulated for this study.
In the assessment of the quality of life of people 
living with HIV/AIDS, according to the levels of 
compliance with the antiretroviral drugs, it was identified 
that the individuals classified and non-compliant with 
the treatment had worse scores on all quality of life 
domains, demonstrating that non-compliance with the 
treatment is a widespread problem, negatively affecting 
patients and the population in general(17).
Conclusion
Compliance with ARVT among the coinfected 
patients was inappropriate in a significant part 
of patients on antiretroviral drugs. In addition, a 
statistically significant difference was observed between 
the levels of compliance with the antiretroviral drugs 
and the length of use of ARVT, sexual orientation and 
the number of children.
The data demonstrated implications related to 
medication adherence and double infection, whose 
appropriate intake of the drugs is needed to achieve 
better clinical and health conditions. In addition, the 
consequences of the lack of compliance particularly affect 
the patients’ survival and can cause higher mortality 
rates among people living with HIV/TB coinfection.
This study appoints the need to develop a specific 
compliance measure for people coinfected with HIV/
TB, thus demonstrating a limitation in the assessment 
of coinfected patients’ compliance, as the analysis was 
restricted to compliance with ARVT only.
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